Adzymes and uses thereof
OwnerNoubar B. Afeyan, Frank D. Lee +3inventors
InventorsNoubar B. Afeyan, Frank D. Lee, Gordon G. Wong, Ruchira DasGupta, Brian Baynes
Life of this patent
Estimating the term…
Loading patent…
OwnerNoubar B. Afeyan, Frank D. Lee +3inventors
InventorsNoubar B. Afeyan, Frank D. Lee, Gordon G. Wong, Ruchira DasGupta, Brian Baynes
Estimating the term…
Disclosed is a family of novel protein constructs, useful as drugs and for other purposes, termed “adzymes,” comprising an address moiety and a catalytic domain. In some types of disclosed adzymes, the address binds with a binding site on or in functional proximity to a targeted biomolecule, e.g., an extracellular targeted biomolecule, and is disposed adjacent the catalytic domain so that its affinity serves to confer a new specificity to the catalytic domain by increasing the effective local concentration of the target in the vicinity of the catalytic domain. The present invention also provides pharmaceutical compositions comprising these adzymes, methods of making adzymes, DNA's encoding adzymes or parts thereof, and methods of using adzymes, such as for treating human subjects suffering from a disease, such as a disease associated with a soluble or membrane bound molecule, e.g., an allergic or inflammatory disease.
An adzyme for inhibiting receptor-mediated signaling activity of an extracellular substrate polypeptide, the adzyme being a fusion protein comprising a protease domain that catalyzes the proteolytic cleavage of at least one peptide bond of the substrate polypeptide so as to inhibit the receptor-mediated signaling activity of the polypeptide, and a targeting domain that reversibly binds with an address site on said substrate polypeptide, wherein said targeting domain and said protease domain are discrete and heterologous with respect to each other.
An adzyme for inhibiting receptor-mediated signaling activity of an extracellular substrate polypeptide, the adzyme being an immunoglobulin fusion complex comprising:
Dependencies are inferred from the claim text.